Cefazolin and Imodium drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Cefazolin (cefazolin sodium) and Imodium (loperamide hydrochloride). Common drug interactions include nausea among females and oedema peripheral among males.
The phase IV clinical study analyzes what interactions people have when they take Cefazolin and Imodium. It is created by eHealthMe based on reports of 72 people who take the same drugs from the FDA, and is updated regularly.
What is Cefazolin?
Cefazolin has active ingredients of cefazolin sodium. It is often used in infection. eHealthMe is studying from 15,157 Cefazolin users. Check the latest studies of Cefazolin.
What is Imodium?
Imodium has active ingredients of loperamide hydrochloride. It is often used in diarrhea. eHealthMe is studying from 45,092 Imodium users. Check the latest studies of Imodium.
72 people who take Cefazolin and Imodium together, and have interactions are studied.

What are the common drug interactions of Cefazolin and Imodium, by gender? *:
female:
- Nausea (feeling of having an urge to vomit)
- Hypertension (high blood pressure)
- Dry skin
- Abdominal pain
- Arthralgia (joint pain)
- Depression
- Dizziness
- Dyspnoea (difficult or laboured respiration)
- Fatigue (feeling of tiredness)
- Muscle spasms (muscle contraction)
male:
- Oedema peripheral (superficial swelling)
- Anaemia (lack of blood)
- Nausea (feeling of having an urge to vomit)
- Arthralgia (joint pain)
- Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
- Atrioventricular block (heart block)
- Pain
- Pneumonia
- Anxiety
- Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
What are the common drug interactions of Cefazolin and Imodium, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Colitis microscopic (inflammation of colon with diarrhoea and abdominal cramps)
- Febrile neutropenia (fever with reduced white blood cells)
- Face oedema (swelling of face)
- Hyperthermia (body temperature greatly above normal)
- Hypoalbuminaemia (levels of albumin in blood serum are abnormally low)
- Oedema peripheral (superficial swelling)
- Pulmonary embolism (blockage of the main artery of the lung)
- Vitamin a deficiency
- Vitamin d deficiency
- Pyrexia (fever)
50-59:
- Hyperuricaemia (level of uric acid in the blood that is abnormally high)
- Muscular weakness (muscle weakness)
- Cellulitis (infection under the skin)
- Chills (felling of cold)
- Chronic kidney disease
- Device related infection
- Ecchymosis (a discoloration of the skin resulting from bleeding underneath)
- Erythema (redness of the skin)
- Memory impairment
- Metabolic encephalopathy (disorder or disease of the brain due to the body's disability to use energy)
60+:
- Haemorrhage intracranial (bleeding within the skull)
- Leukopenia (less number of white blood cells in blood)
- Fatigue (feeling of tiredness)
- Febrile neutropenia (fever with reduced white blood cells)
- Renal failure (kidney dysfunction)
- Abdominal pain
- Anaemia (lack of blood)
- Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
- Atrioventricular block (heart block)
- Muscle spasms (muscle contraction)
What are the existing conditions these people have? *
- High Blood Pressure: 32 people, 44.44%
- Nausea (feeling of having an urge to vomit): 29 people, 40.28%
- Depression: 23 people, 31.94%
- Stress And Anxiety: 22 people, 30.56%
- Insomnia (sleeplessness): 19 people, 26.39%
- Pain: 19 people, 26.39%
- Hypokalemia (low potassium): 18 people, 25.00%
- Anaemia (lack of blood): 15 people, 20.83%
- Short-Bowel Syndrome (a condition in which the body cannot absorb enough fluids and nutrients because part of the small intestine is missing): 14 people, 19.44%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 13 people, 18.06%
* Approximation only. Some reports may have incomplete information.
Do you take Cefazolin and Imodium?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Cefazolin and Imodium:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Cefazolin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Imodium:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Cefazolin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Imodium and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on cefazolin sodium and loperamide hydrochloride (the active ingredients of Cefazolin and Imodium, respectively), and Cefazolin and Imodium (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Epilepsy and Diplopia - 2 seconds ago
- Could Meticorten cause Haematochezia? - 2 seconds ago
- Drug interactions of Cavinton and Xanax - 4 seconds ago
- Drug interactions of Catapres and Zyprexa - 7 seconds ago
- Could Symbicort cause Disease Progression? - 13 seconds ago
- Could Nasonex cause Faecal Incontinence? - 22 seconds ago
- Could Esbriet cause Drug Effect Decreased? - 23 seconds ago
- Dyslipidaemia and Bronchitis - 25 seconds ago
- Could Vancomycin cause Mucormycosis? - 26 seconds ago
- Drug interactions of Afinitor and Eurax - 30 seconds ago